Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion type Assertion NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_head.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion description "[Further, vemurafenib reduced the expression of IL-1 protein in melanoma cell lines and most notably in human tumor biopsies from 11 of 12 melanoma patients undergoing inhibitor treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion evidence source_evidence_literature NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion SIO_000772 22850568 NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion wasDerivedFrom befree-20140225 NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.
- NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_assertion wasGeneratedBy ECO_0000203 NP817065.RAGdvXTxY_OTazalG2D7cGM_f3D0mVGwqsNVcPRlIZ_bs130_provenance.